Bulking Agents for the Treatment of Stress Urinary Incontinence in Females

Trial ID or NCT#

NCT00629083

Status

not recruiting iconNOT RECRUITING

Purpose

The primary purpose of this study is to demonstrate the safety and effectiveness of Bulkamid® in the treatment of stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD) in adult women who have SUI or stress predominant mixed incontinence

Official Title

A Single-Masked, Randomized, Multi-Center, 2-Arm Parallel Study Comparing the Safety and Effectiveness of Bulkamid® and Contigen® as Bulking Agents for the Treatment of Stress Urinary Incontinence in Females

Eligibility Criteria

Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No
Show Less

Contact us to find out if this trial is right for you.

Contact

Tine Bjornlund
6507247826

View on ClinicalTrials.gov